Maplight Therapeutics Inc
Officers & Directors
The company's executive officers include Christopher A. Kroeger, M.D., Chief Executive Officer and Founder, and Erin Foff, M.D., Ph.D., Chief Medical Officer. Each executive officer may terminate their employment at any time. The company does not maintain key person insurance for its executives or employees. Recruiting and retaining qualified personnel in scientific, clinical, manufacturing, sales, and marketing roles is essential to the company's operations. The loss of executive officers or key personnel could hinder development and commercialization efforts and affect business strategy execution. Replacing such individuals may be challenging due to a limited pool of qualified candidates in the industry. The company also relies on consultants and advisors who may have commitments to other organizations, which could limit their availability. The company plans to expand its clinical development, manufacturing, regulatory, sales, marketing, and distribution functions, which may present management challenges. The management team has limited experience managing such growth, potentially impacting the company's ability to handle expansion effectively. The company's focus on multiple central nervous system (CNS) indications may affect the development of specialized expertise. Expansion efforts may result in significant costs and resource diversion. The company monitors employee and contractor classifications in accordance with wage and hour laws and currently has no claims or investigations related to misclassification.
Maplight Therapeutics Inc currently has 133 employees.
|
